Buy This Pharma Stock For +17% Return, In 1 Year: Motilal Oswal

The stock markets in India are under pressure at the moment, due to the Omicron concerns and inflationary worries. However, the pharma stocks are expected to grow this fiscal, according to brokerage firms. The brokerage firm Motilal Oswal has recommended investors